Introduction
Hormone-receptor interactions generate signals that trigger protein kinase-catalyzed phosphorylation events (12). The action of 30 or more catecholamine and peptide hormones, as well as some prostaglandins, proceeds through parallel pathways that elevate intracellular adenosine 3',5'-cyclic monophosphate (CAMP) and lead to activation of the CAMP-dependent protein kinase (PKA). An apparent paradox, highlighted in Fig. 1 , exists in that parallel pathways can all activate the same enzyme, PKA, although it is clear that individual hormones trigger distinct and diverse physiological processes in the same cell. In essence, each hormone elevates CAMP concentrations but promotes PKA-mediated phosphorylation of distinct substrate proteins (12) .
One hypothesis to explain these observations is that individual hormones activate specific pools of PKA activity. A potential mechanism to explain this phenomenon is that individual PKA pools are compartmentalized at their site of action, close to their preferred substrates, and only become active when the appropriate hormone elevates CAMP in that particular microenvironment. For this to occur, PKA must be maintained at the correct intracellular loci in close vicinity to its preferred substrates.
Support for this hypothesis has been provided primarily by the work of Rubin, Erlichman, and others (2-4, 7-13) who have shown that the type II PKA holoenzyme (R22C) is tethered at specific subcellular locations through interaction of its regulatory subunit dimer (R) with specific anchoring proteins. Experimental evidence supporting this hypothesis can be divided into 3 areas. Z) Different hormones activate specific PKA subtypes.
2) CAMP accumulates in different cell compartments in response to different hormones.
3) Type II PKA distribution is dictated by interaction with specific anchoring proteins. As previously stated, PKA is tethered at precise subcellular sites through interactions between the regulatory subunit (RII) and anchoring proteins (12) . In recent months we and others have utilized recombinant DNA and protein chemistry techniques to characterize the site of anchoring protein interaction on RI1 (9, 13).
To establish the minimum region of RIIa required to bind anchoring proteins, a family of RIIcv deletion mutations was constructed, expressed in E. coli, and tested for anchoring activity in a solid-phase binding assay using the cytoskeletal component microtubule-associated protein 2 (MAP2) as a substrate. Anchoring-protein interaction occurs through the first 79 amino acids in each RI1 promoter but, surprisingly, only with the intact RI1 dimer (13). Residues 1-30 represent an independent RIIcr dimerization subdomain, functional when removed from the remainder of the molecule.
Since this region alone is unable to bind MAP2, other regions distal to the dimerization domain must also participate in anchoring-protein interaction Two distinct peptide subdomains found in each RIIa promoter indeed appear to participate in such interaction. A schematic diagram summarizing these findings is presented in Fig. 2 .
Once the components of the MAP2 binding site had been established, other RII-anchoring proteins were screened to see whether they bound the RIIcv dimer. In all cases, disruption of dimerization destroyed anchoring-protein binding. Furthermore, competition studies with P75, a bovine brain anchoring protein, suggest that it binds on RI1 through the same or overlapping sites as MAP2 (13). Therefore, we believe the schematic diagram of the RIIanchoring-protein interaction presented in Fig. 2 function. For example, the anchoring-protein receptor site is immediately adjacent to the autoinhibitor domain in RIIa (Fig. 2) . The RRVSV sequence motif (residues 92-96 in murine RIIcu) is believed to provide a primary contact site with the dormant catalytic subunit.
Therefore, the topology of an anchored type II PKA holoenzyme complex (Fig. 2 ) could place both catalytic subunits in close proximity to the anchoring protein, allowing its rapid and preferential phosphorylation following C subunit activation. In support of this hypothesis, it has been shown that MAP2 is phosphorylated by PKA at multiple sites, incorporating up to 11 moles of phosphate. Separate studies have shown that most RII-anchoring proteins isolated by affinity chromatography on RIIa-Sepharose are also PKA substrates.
Although anchoring-protein contact occurs at sites between residues 30 and 79 on each RIIa protomer, the orientation of these contact sites may be dictated by dimerization, which occurs between residues 1 and 30. We predict that if RIIa protomers dimerize in a parallel alignment, the topology of the anchored holoenzyme complex places both C subunits on the same face of the holoenzyme as the anchoring protein. In this configuration, RII-anchoring proteins would be ideal substrates for the kinase and could be instantly phosphorylated on PKA activation.
Alternatively, if RI1 protomers dimerize in an antiparallel
alignment, one C subunit may face into the anchoring protein, whereas the other will face away from it. In this confirmation, the C subunit would be more able to diffuse and phosphorylate other proteins, within its microenvironment.
Current work in our laboratory is focusing on elucidating the orientation of RIIcv dimerization and the availability of the anchoring protein to the C subunit. (Fig. 3) . Two lines of evidence suggest that this is a conserved RII-binding domain: deletion of the last 26 residues in P75 or the last 15 in P150 destroys interaction with RIIP, whereas expression of the last 107 amino acids of Ht21 alone produces a functional RII-anchoring fragment. While the carboxyl-terminals of all three proteins share a highly conserved RII-binding domain, the remainder of each molecule is structurally distinct. This lack of homology could be explained by species drift, since P150 was cloned from mouse, P75 from bovine, and Ht21 from humans, although this is unlikely because of the degree of divergence.
An alternative and more attractive hypothesis is that the amino-terminal portion of each P75/150 family member is a distinct domain that targets the RII-anchoring protein to specific cellular compartments. Since several anchoring proteins apparently bind to the same or overlapping sites on RIIa, it seemed likely that these molecules share a common RII-binding domain. The site on MAP2 that contacts RIIP has been identified as a 31-residue peptide in the amino-terminal region of the molecule (10, 11), whereas the RIIbinding domains in P75 and P150 are believed to include the last 26 and 15 amino acids of the proteins, respectively (2,s). Comparison of these sequences revealed no striking homology (Fig. 4A) , leading us to examine the RII-binding site in each anchoring protein for a conserved secondary structure binding motif.
Computer-aided secondary structure predictions of each putative RIIbinding site showed a high probability of amphipathic helix formation. The distinction between the hydrophobic and hydrophilic faces can be clearly seen when the sequences are drawn in a helical-wheel configuration (Fig. 4B) . In each RII-anchoring protein there was a similar alignment of acidic residues throughout the hydrophilic face of each putative helix.
Analysis of Ht31, a novel human thyroid RII-anchoring protein of 1,035 amino acids we recently cloned, identified a potential amphipathic helix between residues 494 to 509. This sequence (Leu-Ile-GluGlu-Ala-Ala-Ser-Arg-Ile-Val-AspAla-Val-Ile-Glu-Gln) was 43% identical to region within the RII-binding site of MAP2 (Fig. 4A) . To determine whether residues 494-509 of Ht31 were involved in RI1 binding, a 318-amino acid fragment representing residues 418-736 of Ht31 was expressed in E. coli. Ht3lA 418-736 bound RIIcr as assessed by solidphase binding and gel-shift assays (4) To determine whether an intact amphipathic helix was required for RI1 binding, a family of Ht31 point mutants was produced in the Ht3lA In contrast, proline substitution of Ala 522, which lies 12 residues downstream of the amphipathic helix region, had no apparent effect on RI1 binding.
These results suggest that disruption of protein secondary structure between residues 498 and 507 of Ht31 diminishes or abolishes RI1 bindi .ng. Ret ently, we have synthesized a pepti de that spans the putative amphipathic helix region of Ht31. This peptide binds RIIa with an affinity bf Aapproximately 1 nM Gun .published observation). Circular dichroism analysis of this peptide suggests it can adopt an a-helical conformation.
One chara cteristi .c of the amphipathic helix motif is the ordered placement of alternating pairs of hydrophobic and hydrophilic amino acids within the linear sequence of a protein. In addition to this criterion, each RII-anchoring protein contains acidic amino acids distributed over the hydrophilic face of the helix (4). In particular, an invariant glutamic acid at position 3 is located within the first turn of the amphipathic helix (Fig. 4B) . Therefore, the overall sequence characteristics of an RII-anchoring site appear to be an approximately 14-residue region rich in acidic and hydrophobic amino acids with a high probability for amphipathic helix formation.
The lack of a consensus RI1 binding sequence is consistent with the hypothesis that each molecule contains a common secondary structure. Another example of conserved secon .dary structure is the or so calmodulin .-bindi tami ng P ly of 20 eptides, which exhibit little or no conservation in primary structure other than an abundance of basic and hydrophobic amino acids (6). The basic face of these amphipathi form s ionic i nteractions acidic central helix of calmodulin. In fact, synthe #tic peptid es consisting of alternating pairs of leucine and lysine residues have nanomolar binding affinities for calmodulin.
.C PePt ides with the Because RI1 dimerization is required for binding, it is likely that the amphipathic helix of the RII-anchoring protein interacts with sites on both RI1 subunits. The nature of these interactions is unclear but may involve ionic interactions between the acidic face of the amphipathic helix and basic residues located on both RI1 protomers. Whereas the amphipathic helix region is responsible for RI1 association, it is clear that other regions in each anchoring protein are responsible for specific interaction with membranes, organelles, or the cy toskeleton. This twofold binding could potentially determine the subcellular location of the PKA and, presumably, anchor the kinase in close proximity to its preferred substrates.
Sequence comparison of the four amphipathic helix regions (Fig. 4A) suggests that there may be two classes of RII-anchoring proteins. Ht31 and MAP2 are 43% similar over the 14-residue amphipathic helix region, whereas Ht21 and P150 have 93% sequence similarity (4). It is of interest to note that MAP2 has a sevenfold higher affinity for the RIIa isoform than for RI10 (7).
It will be of interest to establish whether HE1 and Ht31 preferentially bind to a particular RI1 isoform. The differential subcellular distribution of RIIa and RIIP in neurons, demonstrated by electron microscope immunocytochemistry, may reflect, in part, a preferential interaction with distinct RII-anchoring proteins (8). Structural and functional analysis of additional RII-anchoring proteins is required to establish if, in fact, there are two classes of RII-anchoring sites and if they preferentially associate with a specific RI1 isoform. Nevertheless, the preferential interaction of RI1 isoforms with specific classes of RIIanchoring proteins is an attractive mechanism to explain the subcellular localization of different PKA isoforms.
The C subunit may also be adapted for anchoring, since it is myristylated at the amino-terminus (12). Myristylation of several molecules involved in signal transduction such as other protein kinases, phosphoprotein phosphatases, and GTPbinding proteins is commonly thought to promote targeting to sites on or near membranes. However, a mutant C subunit that cannot become myristylated is fully functional (5). It is quite possible that myristylation of the C subunit, in conjunction with anchoring by the regulatory subunits, preferentially maintains the kinase in hydrophobic environments.
Recently, a splice variant of the bovine PKA catalytic subunit, CD:!, has been identified. It contains a putative amphipathic helix at the amino-terminus, replacing the normal myristylation signal (15). The role of this amphipathic helix is unknown, but the authors suggest it may function to tether PKA catalytic subunit to membranes. Potentially, amphipathic helices could be responsible for anchoring both RI1 and CpZ subunits, such that the active catalytic subunit is immobilized and remains close to its regulatory subunit on CAMP activation. Under these conditions, the accessibility of PKA substrates would be tightly controlled and kinase activity would be highly regulated, since rapid reassociation of the holoenzyme complex
